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Metallo-β-lactamases catalyse the 
hydrolysis of most β-lactam antibiotics and hence 
represent a major clinical concern. The 
development of inhibitors for these enzymes is 
complicated by the diversity and flexibility of their 
substrate binding sites, motivating research into 
their structure and function. In this study, we 
examined the conformational properties of the 
Bacillus cereus β-lactamase II in the presence of 
chemical denaturants using a variety of 
biochemical and biophysical techniques. The 
apoenzyme was found to unfold cooperatively, 
with a Gibbs free energy of stabilization (∆G°) of 
32 ± 2 kJ∙mol−1. For holoBcII, a first non-
cooperative transition leads to multiple 
interconverting native-like states, in which both 
zinc atoms remain bound in an apparently 
unaltered active site and the protein displays a 
well-organized compact hydrophobic core with 
structural changes confined to the enzyme surface, 
but with no catalytic activity. 2D NMR data 
revealed that the loss of activity occurs 
concomitantly with perturbations in two loops that 
border the enzyme active site. A second 
cooperative transition, corresponding to global 
unfolding, is observed at higher denaturant 
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concentrations, with ∆G° value of 65 ± 1.4 
kJ∙mol−1. These combined data highlight the 
importance of the two zinc ions in maintaining 
structure as well as a relatively well-defined 
conformation for both active site loops in order to 
maintain enzymatic activity. 
 
β-lactamases catalyse hydrolysis of the β-
lactam ring of antibiotics belonging to the 
penicillin family (1-3). Synthesis of these enzymes 
represents the major cause of bacterial resistance 
to β-lactam antibiotics (4-7). They are classified 
into two structural superfamilies (8), namely the 
active-site serine enzymes (both β-lactamases and 
penicillin binding proteins) and the metallo-β-
lactamases (MBLs). The latter, also referred to as 
class B β-lactamases, require one or two zinc ions 
for activity (9-11). They show no structural 
similarity with the active-site serine β-lactamases 
and they are part of a remarkable set of enzymes 
(i.e. the zinc metallo-hydrolase family of the β-
lactamase fold or, more simply, the MBL 
superfamily (10-16)) that exhibit a wide variety of 
functions related to hydrolysis and redox reactions, 
and DNA and RNA metabolism. Seventeen groups 
of enzymes have been identified on the basis of 
their biological functions (13), which all share a 
novel αβ/βα fold. Most of the 3D structures reveal 
a binuclear centre with metal ligands located on 
loops connecting secondary structure elements 
(15,17). 
Zinc β-lactamases have been found in 
many bacterial species, including pathogenic 
strains (18,19). Most of them are able to hydrolyse 
almost all β-lactam antibiotics (20,21), including 
carbapenems (i.e. a family of last resort β-lactams 
that generally escape the activity of the most 
widespread serine β-lactamases), and they are not 
sensitive to the classical inactivators of serine β-
lactamases, such as clavulanate, sulbactam and 
tazobactam (22,23). Furthermore, these enzymes 
are often encoded by highly transmissible genetic 
elements (i.e. plasmids, transposons and 
integrons), which allow their spreading among 
pathogenic bacteria (5,6,18,24). Thus, MBLs have 
been reported to be of particular concern for public 
health (18;19;24-28) and the development of 
effective inhibitors of zinc β-lactamases to 
counteract the ongoing widespread resistance to β-
lactam antibiotics is of immediate clinical 
relevance. The structural diversity of the MBLs 
and the plasticity of their binding sites, at the level 
of both the zinc centre and the adjacent substrate 
binding loops, render the design of such 
compounds a difficult task (29). This will likely 
not be possible without a detailed understanding of 
both the mechanism of action of these enzymes 
and the interactions which determine the structure-
activity relationships among MBL inhibitors 
(17,23,30,31). This is even more obvious in the 
light of the challenge of overcoming in vivo 
toxicity associated with cross reactivity with 
human metallo-enzymes (32).  
MBLs are grouped according to sequence 
similarities and zinc coordination into subclasses 
B1, B2 and B3 (10,33). Enzymes from each class 
exhibit specific functional and mechanistic 
properties (34,35). In particular, while the B1 and 
B3 enzymes display maximum activity as dizinc 
species, the B2 β-lactamases are inhibited upon 
binding of a second zinc (36). The first class B 
enzyme was isolated from an innocuous strain of 
Bacillus cereus
 (37). This protein, known as BcII, 
is the archetype, most extensively studied model of 
enzymes of the largest, ubiquitous and clinically 
relevant B1 subclass, such as VIM-, IMP- and 
NDM-type MBLs (all transferable broad spectrum 
β-lactamases) (38). BcII consists of 227 residues in 
the mature form (Mr = 24960/25088 in the 
absence/presence of zinc ions) and its three 
dimensional structure (Figure 1, both X-ray crystal 
and solution NMR (31, 39-41)) exhibits the 
classical MBL fold, i.e. a four-layered αβ/βα 
structure, comprising a central β-sheet sandwich 
flanked on either side by two α-helices. The active 
site, with two zinc ions readily accessible to 
solvent, is located at the bottom of a long wide 
groove running on the surface of the protein, at 
one edge of the β-sheet sandwich. The shape of the 
active site cleft is modulated by conformational 
changes of two long loops {β3-β4 [residues 32-
38(59-66)] and β11-α4 [170-188(223-241)]}. 
{Residue numbering is presented as: number in 
BcII sequence(number in standard BBL system) 
(33,42) throughout the text, and all structural 
elements are defined according to the solution 
NMR structure (31)}. Note that these loops have 



















BcII has been reported to be active in the 
presence of either one or two zinc ions at the 
active site, although maximum activity is observed 
with two zinc bound (20,43-45). However, Jacquin 
et al. (46) demonstrated that at 1:1 [Zn]/[BcII] 
ratio the only species present were apoenzyme and 
dizinc enzyme, indicating cooperative binding of 
the zinc ions and suggesting that the dizinc species 
is the only relevant form of the enzyme for activity 
(46). For dizinc MBLs, hydrolysis has been 
suggested to occur by cleavage of the amide bond 
of the β-lactam ring via attack of a hydroxide ion 
on the β-lactam carbonyl carbon, with no 
formation of covalent adducts (17,35,47-49). 
The zinc ion in the first binding site (Zn1 
or histidine site) is coordinated by four ligands in a 
tetrahedral geometry: the nitrogen atom of the 
imidazole groups of three histidine residues 
[His86(116), His88(118) and His149(196)] and the 
oxygen atom of a water molecule or hydroxide 
ion; this oxygen ligand is a bridge to the second 
zinc ion. The zinc in the second binding site (Zn2 
or cysteine site) is coordinated by five ligands: 
three other amino acid side chains [Asp90(120), 
Cys168(221) and His210(263)] in a distorted 
trigonal bipyramidal geometry, an apical water 
molecule and the bridging water/hydroxide, which 
probably acts as the nucleophile in the course of β-
lactam hydrolysis (3,17). 
Zinc-bound β-lactamases appear to be 
more stable than their corresponding metal-
depleted forms (9) and removal of the metal is 
known to induce conformational changes 
(40,46,50). No detailed information on the 
conformational stability of MBLs has, however, 
been reported to date (for a brief review of the 
literature, see the discussion section). In the 
present work, the chemical-induced unfolding 
transitions of both apo- and holoBcII were studied 
by using a combination of spectroscopic 
techniques. This analysis gives insights into the 
role of zinc in stability and provides estimates of 
the thermodynamic parameters. Furthermore, data 
obtained at moderate denaturant concentrations 
indicate population of a heterogeneous ensemble 
of interconverting  partially folded species with 
two zinc ions bound and modest structural changes 
at the enzyme surface, particularly in the two 
active site loops. Observation that these species 
display no significant changes in the geometry of 
the active site but are fully inactive demonstrates 
that both the β3-β4 and β11-α3 loops are important 
structural elements for catalysis. 
This study brings new insights into the role 
of metal cofactors in protein folding as a whole, in 
the absence of any clinical implications. Moreover 
it highlights structural aspects linked to the 
catalytic activity of the enzyme, which are relevant 
to inhibitor discovery. 
 
RESULTS 
The fluorescence spectra of holo and 
apoBcII (Figures 2A,B), measured at pH 7.5, 
25°C, are similar and display a broad emission 
band with maxima at 329 and 334 nm, 
respectively. These relatively low maximum 
emission wavelengths (λmax) are consistent with 
low solvent exposure of the four tryptophan indole 
side chains, as seen in the enzyme 3D structure 
(Figure 1). In 4 M GdmCl, λmax is shifted to 355-
356 nm (Figures 2A,B), indicating full solvent 
accessibility of tryptophan indole groups. The 
near-UV CD spectra (not shown) of free and 
metal-bound BcII are also similar, although not 
identical, indicating a well-defined tertiary 
structure in both cases. The far-UV CD spectra of 
holo and apoBcII, shown in Figures 2C,D, reveal a 
significant decrease in helical content of the 
enzyme in the absence of zinc; this was previously 
estimated to be around 10 % (46). With both apo- 
and holoenzyme, addition of high concentrations 
of denaturant led to a dramatic reduction of the CD 
signal (Figures 2C,D), consistent with a major 
decrease in secondary structure organization. 
 Incubation of both apo- and holoBcII 
(0.15 mg∙mL−1, i.e. 6 µM) for 12 h in 6 M GdmCl, 
and subsequent dilution, restored fluorescence and 
far-UV CD spectra that are indistinguishable from 
those of the native state, indicating that GdmCl-
induced unfolding is fully reversible for both 
forms of the enzyme. With holoBcII, this could be 
further demonstrated by measuring full recovery of 
the enzyme activity after unfolding/refolding 
cycles. Thus, fluorescence and CD spectroscopy 
were used to follow unfolding transitions of the 
enzyme by GdmCl and urea. 
Unfolding of apoBcII–With the metal-


















the transition curves obtained by intrinsic 
fluorescence and far-UV CD measurements 
(Figure 2F) indicated that secondary and tertiary 
structures were destabilized concomitantly. The 
unfolding curves for the GdmCl-induced 
denaturation in the absence of zinc can be 
described by an apparent cooperative two-state 
model (N ⇌ U), where only the native and 
unfolded states are significantly populated. 
Dilution of the fully denatured enzyme (in 6 M 
GdmCl) into final denaturant concentrations 
corresponding to the transition zone (i.e. 1-2 M 
GdmCl) showed that the process was monitored 
under genuine equilibrium conditions and occurred 
with full thermodynamic reversibility. Therefore, 
values of the thermodynamic parameters were 
calculated assuming a simple two-state model 
(Table 1). Notably, values obtained for the Gibbs 
free energy of unfolding (ΔG°NU) were identical, 
within the error limit, for both optical methods and 
also for unfolding induced by either GdmCl or 
urea, providing convincing evidence for a simple 
two-state unfolding mechanism. 
Unfolding of holoBcII–By contrast, in 
spite of full thermodynamic reversibility, unfolding 
of holoBcII with both GdmCl (Figure 2E) and urea 
(data not shown) displayed non-cooperative 
behaviour, with at least two unfolding transitions. 
However, since the enzyme was not fully unfolded 
in 10 M urea (note that no significant unfolding 
could be observed by both intrinsic fluorescence 
and far-UV CD measurements at concentrations 
below 7 M), data obtained using this denaturant 
were not further analysed. 
With GdmCl, the first and second 
transitions occurred with midpoint values of 1.9 
and 2.8 M, respectively. Both were characterized 
by changes in intrinsic fluorescence and far-UV 
CD (Figure 2E; also near-UV CD, data not 
shown). These data indicate population of species 
with intermediate conformations that are in 
equilibrium with native and fully unfolded enzyme 
molecules. Optical measurements at 2.4 M GdmCl, 
i.e. close to the end of the first apparent transition, 
suggest the existence of a stable intermediate state 
that retains both a high content of native secondary 
structure, as deduced from the far-UV CD 
spectrum shown in Figure 2C, and a significant 
protection of the tryptophan residues from the 
solvent, as indicated by the fluorescence spectrum 
shown in Figure 2A. The fluorescence and far-UV 
CD data shown in Figure 2E were analysed 
separately on the basis of a three-state model 
(N ⇌ I ⇌ U), using equation (3), and the 
corresponding thermodynamic parameters are 
given in Table 2. GdmCl-induced unfolding of 
holoBcII was also followed by activity 
measurements (Figure 2E), which indicated that 
the catalytic activity is lost in a single transition, 
with a midpoint of 1.9 M, concurrent with the first 
transition observed by optical methods. The 
possibility of a denaturant ionic strength effect 
could be excluded by showing that no significant 
change in enzymatic activity occurred in the 
presence of NaCl at concentrations up to 3 M (not 
shown). The intermediate state that is apparently 
populated for the first unfolding transition is thus 
totally inactive, suggesting a change in specific 
tertiary and/or secondary structure organization at 
the enzyme active site, and possibly zinc release. 
Finally, GdmCl-induced unfolding was 
also performed in the presence of the hydrophobic 
dye ANS; fluorescence measurements at 475 nm 
revealed no significant enhancement in intensity, 
and thus no ANS binding, indicating that no 
species (such as a molten globule (62)) having 
significant hydrophobic regions exposed to the 
solvent is significantly populated (63-65). 
Characterization of the intermediate state–
Since the intermediate state is enzymatically 
inactive, one obvious possibility is that the 
catalytically essential zinc atoms have dissociated 
from the enzyme. To gain more insight into the 
presence of zinc during holoBcII unfolding, the 
imidazole resonances of the histidine residues 
involved in the coordination of zinc ions (i.e. 
His86(116), His88(118) and His149(196) of the 
histidine site, and His210(263) of the cysteine site) 
were followed as a function of GdmCl 
concentration. Figure 3A shows 1H-15N HSQC 
spectra focusing on the imidazole signals in the 
presence (holoBcII) and absence (apoBcII) of zinc, 
with no GdmCl. The imidazole resonances of the 
four histidines are well defined and assigned when 
zinc ions are bound to the catalytic site (51), but 
not in their absence. The clear difference between 
holo- and apoBcII in the NMR crosspeak pattern 


















of the effect of various GdmCl concentrations on 
the binding of zinc. At all GdmCl concentrations 
between 0 and 2.5 M, imidazole signals of the four 
binding histidines could be distinctly observed 
(Figure 3B). Furthermore, the increase of GdmCl 
concentration from 0 to 2.5 M caused only slight 
displacements of the imidazole signals (Figure 
3B), close to the experimental error, suggesting 
little change in the geometry of the zinc binding 
sites. These data unambiguously demonstrate that 
the two zinc ions are bound to their respective sites 
throughout the first unfolding transition and 
therefore, the loss of enzymatic activity is not due 
to the release of zinc. Furthermore, while there is 
evidence that the zinc ions have the flexibility to 
move significantly within the active site (31,66), 
the very modest shifts of the imidazole crosspeaks 
of the zinc ligands suggest that addition of 2.5 M 
GdmCl not only does not lead to the release of the 
zinc atoms but in fact has very little effect on the 
structure of their coordination sites. 
The dynamic accessibility of the 
tryptophan residues in folded ([GdmCl] = 0 M), 
intermediate ([GdmCl] = 2.4 M) and unfolded 
([GdmCl] = 3.5 M) states of holoBcII was 
investigated using acrylamide as a fluorescence 
quencher (67). As the acrylamide concentration 
was increased, the fluorescence intensity decreased 
without a noticeable change in spectral shape and 
the data were analysed according to equation 1 to 
determine the quenching constant (Ksv) (Figure 4). 
Complete unfolding of holoBcII in the presence of 
3.5 M GdmCl caused a ca. 4.5-fold increase of the 
Stern-Volmer quenching constant, from 1.8 ± 0.1 
(in the absence of denaturant) to 8 ± 0.2 M-1, 
attributable to high solvent exposure of tryptophan 
side chains in the unfolded protein. By contrast, 
the Stern-Volmer quenching constant in 2.4 M 
GdmCl, i.e. Ksv = 1.9 ± 0.2 M
-1, is identical to that 
of the folded state, showing no significant change 
in the solvent accessibility of the tryptophan 
residues under these conditions. 
To obtain amino-acid specific information 
on the unfolding mechanism of BcII, a series of 
2D 1H-15N HSQC NMR spectra was recorded 
under equilibrium conditions in the presence of 
various GdmCl concentrations in the range from 0 
to 4 M. These experiments were performed at 
pH 6.5, rather than pH 7.5, in order to slow down 
intrinsic amide hydrogen exchange. Figure 5 
shows representative spectra of 15N-BcII, collected 
in the presence of 0, 1.63, 2.34 and 4 M GdmCl. In 
the absence of denaturant (Figure 5A), the protein 
spectrum showed a set of well-dispersed peaks 
characteristic of the folded state (68). At 4 M 
GdmCl (Figure 5D), all native enzyme signals 
disappeared and the spectrum is typical of an 
unfolded protein. At intermediate GdmCl 
concentrations (e.g. 1.63 and 2.34 M), 
corresponding to the first unfolding transition (see 
Figure 2), spectra (Figures 5B,C) were similar to 
that of the folded state (Figure 5A). Changes in 
both chemical shift and peak intensity could be 
observed throughout the entire range of denaturant 
concentrations. Up to 1.5 M GdmCl, all peaks 
displayed chemical shifts close to their native state 
values, although with reduced intensities (probably 
due to exchange broadening), whereas at higher 
denaturant concentrations, disappearance of some 
peaks occurred. At 2.34 M GdmCl, some peaks 
corresponding to the unfolded state could be 
observed (Figure 6).  
Based on the resonance assignments of 
native holoBcII (68), assignments of the 
resonances of the enzyme in the presence of 
GdmCl concentrations ranging from 0 to 2.34 M 
could be achieved simply by following chemical 
shift changes as a function of denaturant 
concentration. The chemical shifts of 184 out of 
227 residues (Figure 7) were monitored in this way 
and, for most of them, changes occurred 
progressively and linearly with denaturant 
concentration. For 6 residues (i.e. Lys134(181), 
Lys147(194), His149(196), Leu178(231) and also 
two unassigned ones), non-linear (i.e. curved; see 
Figure 6) chemical shift changes were observed, 
however, suggesting that more than two states (i.e. 
in addition to N and I) are involved. 
A detailed analysis of the chemical shift 
data (Figure 7) showed that 59 residues were 
significantly perturbed by the denaturant (i.e. 
CSP > 0.064 ppm between 0 and 2.34 M GdmCl). 
Among these, the signals of 8 residues [Lys50(78), 
Thr64(92), Glu72(100), Ile83(113), Ala115(146), 
Thr131(178), Val165(218), Glu188(243)] 
disappeared completely as GdmCl concentration 
was increased above 0.75 M, presumably as a 
result of exchange broadening due to a large shift 
difference between the native and intermediate 


















significantly exposed to the solvent (as computed 
with NACESS (69)), are represented schematically 
on the structure in Figure 7B. 32 of them are 
located in loop regions, while the remaining 27 
residues are found essentially at the ends of well-
organized secondary structure elements, i.e. 16 in 
β-strands and 11 in α-helices (Figure 7B). These 11 
residues in α-helices correspond to ca. 18 % of the 
total number of α-helical residues in the enzyme 
structure, which is in good agreement with the ca. 
17 % loss in negative ellipticity measured at 222 
nm, between 0 and 2.4 M GdmCl (Figures 2C,E). 
These data suggest that the denaturant induces 
significant conformational changes in the 
corresponding regions of the polypeptide 
backbone. We were able to follow specifically the 
resonances of 50 residues whose backbone amides 
are fully buried in the enzyme core (as computed 
with NACCESS (69)), and we observed that they 
do not undergo any significant shift perturbation 
(Table S1), with the exception of Val25(52), 
Leu63(91), Leu67(95) and Val207(260), which are 
in fact positioned close to polar residues that 
experience significant shift changes. Most 
importantly, HSQC spectra collected in the 
presence of urea (data not shown) yielded similar 
results, thus indicating that no ionic strength effect 
was observed with GdmCl. In the case of residues 
located around the active site, these results are in 
good agreement with the observation that addition 
of 3 M NaCl had no effect on the enzyme activity 
(see above). 
Figure 8 shows CSPs of the amide and 
indole 1H-15N signals of the four tryptophan 
residues. Progressive and approximately linear 
shift changes occur with increasing GdmCl 
concentrations, in good agreement with the 
behaviour of most of the backbone resonances. 
The side chain of Trp189(244), which is 
completely buried in the core of the native protein, 
showed only minor chemical shift perturbation 
(0.02 ppm, see Figure 8) in the presence of the 
denaturant, indicating the high stability of its 
immediate environment during the first unfolding 
transition. Accordingly, residues in the vicinity of 
Trp189(244) remained in a native-like state up to 
at least 2.4 M GdmCl. By contrast, indole groups 
of Trp59(87) and Trp157(204) are more exposed to 
the solvent and their environment proved to be a 
little more sensitive to the denaturant, as shown by 
CSPs of 0.08 ppm and 0.06 ppm, respectively, in 
2.34 M GdmCl (Figure 8). Finally, Trp26(53) side 
chain, which shows very limited solvent 
accessibility, underwent a dramatic chemical shift 
perturbation at low GdmCl concentration. Thus, 
the CSP was 0.14 ppm at 0.5 M GdmCl and the 
signal totally disappeared at higher concentrations, 
probably due to exchange broadening. Since the 
emission fluorescence intensity of the enzyme 
measured at 370 nm does not change significantly 
in the presence of GdmCl concentrations lower 
than 1.5 M (Figure 2E), these results suggest that 
Trp59(87) and/or Trp157(204), and not Trp26(53) 
are responsible for the increase in intensity 
observed at higher concentrations (Figures 2A,E). 
For all four tryptophan residues, however, up to 
2 M GdmCl the backbone resonance CSP (Figure 
2B) remained below the computed threshold for 
significant CSP (CSP > 0.064 ppm), in good 
agreement with the view that the enzyme 
hydrophobic core remains largely unaffected. 
Refolding of apoBcII by the addition of 
zinc ions–Transition curves for apo and holoBcII 
(Figures 2E and 2F, respectively) highlight 
significant differences in their conformational 
stabilities (see also Tables 1 and 2). Thus, at ca. 
2 M GdmCl, whereas apoBcII is completely 
unfolded, its dizinc counterpart adopts a native-
like, although catalytically inactive, conformation. 
Using 1H-15N HSQC experiments for selective 
observation of His imidazole, as described above, 
we monitored refolding of BcII unfolded in 2 M 
GdmCl in the absence of zinc, upon addition of 
one and two molar equivalents of zinc (Figure 9). 
In the presence of denaturant, addition of zinc 
caused changes in the spectrum of the enzyme, 
with the concomitant appearance of narrow peaks 
corresponding to histidine imidazole signals of 
native holoBcII, and disappearance of the broad 
peaks characteristic of the histidine imidazole 
signals of the unfolded protein. At a Zn/BcII molar 
ratio of 1, the histidine imidazole 1H-15N HSQC 
spectrum (Figure 9C) showed a peak distribution 
consistent with significant population of both 
unfolded and dizinc-bound BcII. The absence of 
any signal for a putative monozinc form indicates 
cooperative binding of the two metal ions (46). 
Finally, in the presence of two equivalents of zinc 
(i.e. Zn/BcII molar ratio of 2), complete recovery 


















BcII is observed. These results demonstrate that 
even in the presence of 2 M GdmCl, zinc binds 
cooperatively to the enzyme and hence shifts the 
reversible denaturation by GdmCl from an 
unfolded state to a native-like intermediate state. 
 
DISCUSSION 
As reported before (46,51,70), the metal-
depleted form of the enzyme is catalytically 
inactive and displays significant changes in its 
spectroscopic properties, suggesting both a 
catalytic and structural role for the metal ions in 
BcII β-lactamase. The conformational properties of 
both metal-free and dizinc forms of BcII β-
lactamase were probed using chemical 
denaturants. Full reversibility of the unfolding 
process was established by both spectroscopic 
methods (i.e. fluorescence, CD and NMR) and 
enzymatic assays. In particular, imidazole-
optimized HSQC experiments (Figure 9) showed 
that zinc binding to the apoenzyme unfolded in the 
presence of 2 M GdmCl shifts the equilibrium to 
the intermediate partially folded state. 
Equilibrium folding experiments showed 
major destabilization of the enzyme in the absence 
of zinc. Thus, although unfolding of BcII proved to 
be fully reversible in both the absence and 
presence of zinc (Figures 2 and 9), transition 
curves obtained by measuring fluorescence and 
CD (Figures 2E,F) showed clear differences. 
While unfolding of apoBcII starts at 1 M GdmCl 
and follows a simple two-state cooperative 
transition (N ⇌ U), with Cm = 1.5 M (i.e. transition 
midpoint), the metal-bound β-lactamase remains 
fully active in the presence of 1.5 M GdmCl and, 
at higher denaturant concentrations, unfolds non-
cooperatively in an apparent three-state transition 
(N ⇌ I ⇌ U), with Cm values of ca. 1.9 and 2.8 M. 
These data are consistent with heat-induced 
denaturation of the enzyme (71). Thus, unfolding 
of the metal-bound species was best described by a 
three-state model, with apparent Tm values of 
72 ± 2 and 85 ± 3°C (71), whereas the apoenzyme 
was found to unfold in a to a two-state transition, 
with apparent Tm = 62.3 ± 0.02°C (71). Thermal 
unfolding of both enzyme forms proved 
irreversible, however, and thus no further 
quantitatiove analysis could be performed. 
Analysis of apo- and holoBcII chemical-
induced unfolding curves was performed on the 
basis of two- and three-state models, respectively, 
and fitting the corresponding equations to the data 
in Figures 2E,F yielded values of the 
thermodynamic parameters displayed in Tables 1 
and 2. With both forms, transition curves obtained 
by intrinsic fluorescence and far-UV CD 
measurements (also near-UV CD, not shown) 
indicated that secondary and tertiary structures are 
destabilized simultaneously, albeit in one and two 
transitions in the absence and presence of zinc, 
respectively. This analysis suggests that in the 
presence of zinc,  a partially folded state with 
reduced fluorescence and CD signal intensities is 
maximally populated at ca. 2.4 M GdmCl. The 
coincident loss in both signals at all denaturant 
concentrations, combined with the absence of ANS 
binding, discards the possibility of a molten 
globule intermediate (62-65).  
For apoBcII, the Gibbs free energy of 
unfolding (∆G°NU) was calculated to be 32 ± 2 
kJ∙mol−1 (Table 1) and the corresponding mUN 
(= - mNU) values are 20 ± 1 and 9.9 ± 0.2 
kJ∙mol−1∙M−1 for GdmCl and urea, respectively. 
Interestingly, the experimental mUN values are 10-
20% smaller than predicted from the expected 
change in solvent accessible surface area upon 
folding (22.2 and 13 kJ∙mol−1∙M−1 in GdmCl and 
urea, respectively; estimated from the size of the 
enzyme (72)), a finding consistent with an increase 
of the protein surface exposed to solvent in native 
apoBcII. On the basis of a three-state model, 
values of the thermodynamic parameters (i.e. 
∆G°NU and mUN) for holoBcII were found to be 80-
95 kJ∙mol−1 and 30-40 kJ∙mol−1∙M−1, respectively 
(Table 2). Whereas for the second structural 
transition, fluorescence and CD measurements 
yielded values that are identical within the error 
limit (Table 2), major differences between these 
two measurements appeared for the first transition. 
In both cases, the global ∆G°UN value (≥ 80 
kJ∙mol−1) is significantly greater than the 20-60 
kJ∙mol−1 found in textbooks (see e.g. (73-76)) for 
most proteins. Furthermore, the corresponding 
experimental mUN value (≥ 30 kJ∙mol
−1 in GdmCl) 
is also well above that calculated from the size of 
the protein (22.2 kJ∙mol−1 (72)). Thus, values of 
the thermodynamic parameters in Table 2 suggest 


















description of holoBcII unfolding. This is further 
supported by the observation that a number of 
residues, notably Leu178(231) in the β11-α4 loop, 
show a non-linear dependence of their amide 
chemical shifts on GdmCl concentration in the 
range 1.0 – 2.34 M (Figure 6), indicating the 
presence of more than two states in this 
concentration range. 
Aiming at a better description of the 
unfolding mechanism of BcII metallo-β-lactamase, 
we analysed in detail the structural features of the 
intermediate state that apparently forms in a non-
cooperative manner at moderate GdmCl 
concentration (Figures 2A,C,E). While the enzyme 
was found to lose its activity in the 1.5-2.5 M 
GdmCl concentration range, optical methods 
indicated population of a partially folded state, 
which is not a molten globule and which displays a 
high content of structural organization, at both the 
secondary and the tertiary levels. Thus, far-UV CD 
measurements indicated that the protein retains ca. 
83 % of its α-helical content in the presence of 
2.4 M GdmCl and both fluorescence quenching 
and ANS binding experiments suggested 
conservation of a compact and well-organized 
protein core. 2D NMR experiments allowed the 
effect of both GdmCl and urea to be monitored at 
the level of individual residues. In particular, long-
range 1H–15N HSQC for selective observation of 
His imidazole resonances demonstrated that the 
loss of catalytic activity, concomitant with the first 
transition observed by optical methods, is not due 
to the loss of zinc from the enzyme active site, 
which in fact remains occupied by both metal ions 
up to 2.5 M GdmCl, with no significant change in 
its geometry. Classical 1H–15N HSQC experiments 
were performed in the presence of GdmCl and 
urea to probe the effect on the environment of 184 
and 181 residues, respectively, out of 227 in the 
full-length protein. In the GdmCl and urea 
concentration ranges of 0 to 2.34 M and 0 to 
7.9 M, respectively, 2D NMR data showed 
progressive changes of the chemical shift of many 
residues, with significant (CSP > 0.064 ppm and 
CSP > 0.079 ppm, respectively) perturbations for 
59 and 40 residues, respectively. These data 
suggest a gradual transition from the native state to 
intermediate states with only modest structural 
changes as indicated by the NMR spectra. These 
changes are seen to occur at the surface of the 
enzyme structure and are well localized in loop 
structures, and at the N- and C-terminal 
extremities of α-helices and β-strands. HSQC 
experiments thus confirm population of globular 
species, with a well-organized, compact, solvent-
protected hydrophobic core. Upon increasing 
GdmCl concentration in the range of 1.5 to 2.5 M, 
the equilibrium between these interconverting 
folding intermediates is shifted towards the less 
structured one, characterized by a reduction of ca. 
17 % and ca. 25 % in CD (at 222 nm) and 
fluorescence (at 370 nm) intensity, respectively. 
Thus, all the data are consistent with the first 
transition leading to the non-cooperative formation 
of a heterogeneous ensemble of native-like protein 
molecules, with two zinc ions bound in the active 
site but no catalytic activity. A single distinct 
folding intermediate (e.g. molten globule) is not 
formed and a simple three-state model cannot be 
used to fit the data. In contrast, the second 
transition from these multiple interconverting 
native-like species to the fully unfolded state 
seems to occur with full cooperativity. 
Interestingly, the corresponding m value 
(mIN = 23.5 ± 0.7 kJ∙mol
−1∙M−1) is about the same 
than that calculated for the native enzyme 
(mUN = 22.2 kJ∙mol
−1∙M−1(72)), suggesting that the 
surface that is not accessible to the solvent 
becomes entirely exposed in this transition. This 
observation strengthens the conclusion that the 
first transition leads to the formation of native-like, 
zinc-bound species, with no significant opening of 
the protein structure and only limited, superficial, 
conformational changes. These are sufficient, 
however, to cause complete enzyme inactivation. 
Finally, our results reveal that global 
unfolding of the protein takes place over a narrow 
GdmCl concentration range of 2.5 to 3.0 M, in a 
cooperative transition characterized by a Gibbs 
free energy change (∆G°) of 65 ± 1.4 kJ∙mol−1 and 
a corresponding m value of 23.5 ± 0.7 
kJ∙mol−1∙M−1. These values are compatible with 
unfolding of the enzyme occuring in a single 
cooperative transition, from native-like 
intermediate species to the fully unfolded state. 
Although holoBcII β-lactamase is remarkably 
stable, removal of zinc, however, causes a 
dramatic destabilization of ca. 35 kJ∙mol−1. This 
finding is consistent with current knowledge that 


















the bound protein (77,78). The effect of zinc on the 
stability of three other MBLs was studied in some 
details. With subclass B1 BlaB and VIM-4 β-
lactamases, zinc ions were observed to stabilize 
the enzyme. GdmCl unfolding of BlaB (79) 
monitored by intrinsic fluorescence measurements 
occurred at significantly lower denaturant 
concentration for the apoform than for the two 
zinc-bound species. Although the data were 
interpreted on the basis of a three-state model, the 
lack of reversibility observed in experiments 
measuring the restoration of catalytic activity 
seriously compromises any quantitative analysis. 
With VIM-4 (80) a dramatic decrease in thermal 
stability (i.e. a drop of 27°C in the apparent Tm 
value) was observed in the absence of zinc. 
Likewise, with CphA β-lactamase (36), a subclass 
B2 carbapenamase which is active in the monozinc 
form only, the catalytic zinc was found to increase 
the thermal stability by ca. 14°C, whereas the 
dizinc inactive form was found to be even more 
resistant to temperature (i.e. a further increase of 
4°C in Tm) than the monozinc enzyme. Finally, 
study of human glyoxalase II (81), another enzyme 
of the MBL superfamily, suggested that 
chemically-induced unfolding is a multistep 
process. Very low GdmCl concentrations (< 1 M) 
were seen to inactivate the enzyme, with no release 
of zinc and no significant optical changes (both 
intrinsic fluorescence and CD), an observation 
which is reminiscent of what is found in the 
present work. Further increase in denaturant 
concentration led, however, to the formation of a 
molten globule (with apparent maximum 
population at 1.2 M (81)), before leading to 
complete unfolding at concentrations above 3 M. 
All the results in this work point at the 
major structural role of zinc. Up to ca. 2.5 M 
GdmCl, the presence of zinc in the active site 
appears to lock the protein in an ensemble of 
native-like structures. The NMR experiments, 
however, show that there are definite, though 
limited, structural changes at the enzyme surface, 
at this GdmCl concentration. These limited surface 
changes must give rise to the observed loss of 
catalytic activity. In particular, substantial CSPs 
are seen to occur in the β3-β4 [residues 32-38(59-
66)] and β11-α4 [170-188(223-241)] loops that 
flank the enzyme active site, and also for 
Asp90(120) in the Zn2 site. It is notable that all 
these residues also show substantial CSPs on the 
binding of an inhibitor to the active site (31). The 
large CSP observed for Asp90(120) in this work 
(Figure 7) most likely results from changes in its 
environment and not in its position, since 
observation of imidazole chemical shifts 
demonstrated that the geometry of both Zn binding 
sites remains largely unaffected by GdmCl 
concentrations below 2.5 M. As for the loops, both 
have been well documented to be flexible and to 
modulate, by conformational changes, the shape of 
the active site (see references below). The NMR 
solution structure (31) showed that, despite 
significant flexibility, both structural elements 
display a relatively well-defined conformation. 
They are generally considered to play a critical 
role for catalytic activity, especially in the ability 
of MBLs to hydrolyse β-lactam antibiotics of very 
diverse structures (for recent detailed reviews, see 
(11,17)). In particular, the β3-β4 loop [32-38(59-
66)] (also known as the “mobile loop” or “flap”), 
which is conserved in most class B1 MBLs, has 
been shown to move towards bound inhibitors and 
substrates, and thus to contribute to the formation 
of a hydrophobic pocket which is important for 
ligand binding (see e.g. (31,40,82-100)). Together 
with the “flap”, the β11-α4 loop [170-188(223-
241)] on the other side of the active site also 
contributes to the capacity of MBLs to bind a 
structurally broad range of substrates and 
inhibitors (87,89,90,100). In particular, recent 
crystal structures of NDM-1 MBL (100,101) have 
provided further evidence that residues Lys(224) 
and Asn(233) (BBL numbering; these two residues 
are conserved in BcII, IMP-1 and CCrA; His(224) 
and Tyr(224)/Arg(228) are found in VIM-1 and 
VIM-2, respectively) in the β11-α4 loop play a 
direct role in substrate binding and hydrolysis. A 
combination of structural and computational 
studies of NDM-1 (66) has led to the suggestion 
that movements of the two loops are important not 
only in substrate binding but also in the hydration 
of the active site, including the water molecules 
which play a central role in the catalytic 
mechanism. Observation in this work that 
relatively modest structural changes in the partially 
folded species, particularly in the two active site 
loops, lead to complete loss of catalytic activity 
provides further evidence that these structural 


















catalytic activity and thus are relevant to the 
discovery of effective inhibitors. 
 
EXPERIMENTAL PROCEDURES 
Enzyme and Chemicals–Ultrapure 
guanidinium chloride (GdmCl) and 
benzylpenicillin were purchased from Sigma-
Aldrich. All other chemicals were of reagent grade. 
Both the recombinant (46) and uniformly 
15N isotopically enriched (51) β-Lactamase II from 
Bacillus cereus 569/H/9 (BcII) were expressed and 
purified as described. The enzyme concentration 
was determined by absorbance measurements at 
280 nm, using a molar extinction coefficient value 
of 30500 M-1·cm-1 (43). 
The metal-free BcII enzyme (apoBcII) was 
prepared following the procedure described in 
Jacquin et al. (46). All final preparations were 
stored at -20°C. 
Buffers–Unless otherwise mentioned, 
experiments were performed in 10 mM Hepes 
buffer, pH 7.5, with 300 mM NaCl in the presence 
(holoBcII) or absence (apoBcII) of 0.1 mM 
ZnSO4. GdmCl and acrylamide solutions were 
prepared in the same buffer, and, if necessary, pH 
was adjusted to 7.5 with HCl or NaOH.  
Enzyme Activity Measurements–
Hydrolysis of benzylpenicillin was monitored by 
measuring absorbance changes at 235 nm using a 
Specord 200 spectrophotometer (Analitik Jena) 
equipped with a thermostatically controlled cell 
holder. Values of the kinetic parameters were 
determined at 30°C in 10 mM Hepes, pH 7.5, as 
described (52). 
Chemical-Induced Unfolding Transitions–
Unfolding was studied at 25°C. Samples at various 
denaturant (GdmCl and urea) concentrations were 
allowed to equilibrate for at least 12 h (under these 
conditions, equilibrium is reached throughout the 
transition, see results). Unfolding and refolding 
transitions were obtained by monitoring the 
changes in intrinsic fluorescence emission 
(λexc = 280 nm; λem = 370 nm) and circular 
dichroism (CD) at 222 nm, using a Varian Cary 
Eclipse spectrofluorimeter and a Jasco J-810 
spectropolarimeter, respectively, both equipped 
with a thermostatically controlled cell holder. With 
all samples, the data were corrected for the 
contribution of the solution (buffer + denaturant). 
Unfolding of holoBcII was also monitored by 
measuring enzyme activity, as described above. 
Denaturant concentrations in the samples were 
determined from refractive index measurements 
(53) using a R5000 hand-held refractometer from 
Atago (Japan). Protein concentrations of ca. 
0.15 mg·ml-1 (6.0 µM) were used throughout.  
Quenching of Tryptophan Fluorescence by 
Acrylamide–All fluorescence experiments were 
performed at 25°C using a protein concentration of 
0.10 mg·ml-1 (4 µM). The enzyme was diluted 
with acrylamide concentrations ranging from 0 to 
0.2 M and tryptophan fluorescence emission 
spectra were recorded from 305 to 450 nm, 
following excitation at 295 nm. Each spectrum 
was the average of five acquisitions and was 
corrected for the contribution of the solution. The 
solvent accessibility of tryptophan residues was 






+=     Equation 1 
where F0 and F are the tryptophan fluorescence 
intensities (computed as areas below the curves for 
the tryptophan emission fluorescence spectra) in 
the absence and presence of acrylamide, 
respectively, Ksv is the Stern-Volmer quenching 
constant and [Q] is the molar concentration of 
acrylamide.  
Nuclear Magnetic Resonance (NMR)–Freeze-dried 
15N labelled holoBcII was dissolved in 10 mM 
Hepes buffer (pH 6.5), containing 300 mM NaCl 
and 0.1 mM ZnSO4, to give a final enzyme 
concentration of 10 mg·mL-1 (400 µM) in the 
presence of GdmCl or urea concentrations ranging 
from 0 to 4 M or 0 to 7.9 M, respectively. NMR 
spectra were collected using a home-built 
750 MHz NMR spectrometer, controlled with 
GE/Omega software and equipped with an Oxford 
Instruments Co. magnet and a home-built triple-
resonance pulse-field-gradient probe head. 
Spectral widths of 10204.08 Hz and 2659.57 Hz in 
F2 (1H) and F1 (15N) respectively, were used for 
2D 1H-15N HSQC spectra. All spectra were 
collected at 25°C, processed with NMRPipe (55) 


















For chemical-induced unfolding under 
equilibrium conditions, the concomitant population 
of folded and unfolded species in the transition 
region is accompanied by changes in the NMR 
spectrum, both in terms of peak intensity and 
chemical shifts. The combined chemical shift 
perturbation (CSP) was calculated as follows (57): 
 = ∆	
H + 0.15 × ∆	
N 
Equation 2 
where δ represents the chemical shift in ppm. 
In order to determine significant shift 
changes, we defined a threshold value, as follows. 
In a first step, all shift distances were considered 
and averaged (<CSP>), with errors calculated at 
the 95 % confidence limit (i.e. twice the standard 
deviation, σ). Then, the highest shift changes 
(CSP ≥ <CSP> + 2σ) were removed from the data 
and a new <CSP>, with standard deviation, was 
calculated. This operation was repeated until all 
data lie within 2 sigma values of the average Tand 
the final <CSP> + 2σ value corresponds to the 
threshold below which the residues are not 
significantly perturbed. 
The 2D 1H-15N HSQC experiments for the 
observation of histidine imidazole groups were 
carried out with a total dephasing delay of 
16.67 ms, at 25°C, on a Bruker Avance 600 MHz 
NMR spectrometer equipped with a cryoprobe. 
The apoprotein concentration was 12.5 mg·mL-1 
(500 µM) in 10 mM HEPES, 300 mM NaCl, 
pH 7.5. One and two molar equivalents of zinc 
ions were added to the same sample. 
Data Analysis–Unfolding curves were 
analysed on the basis of a two-state (N⇌U) or a 
three-state (N⇌I⇌U) model, according to 
Vandenameele et al. (58) and equation 3, 
respectively. This analysis is based on the 
assumption that the differences in Gibbs free 
energy between various species exhibit a linear 





















yobs is the measured parameter at a given 
denaturant concentration, and yN, yI and yU are the 
values of this parameter for the folded, partially 
unfolded (intermediate) and unfolded states, 
respectively, at the same denaturant concentration. 
The observed linear dependence of this parameter 
on denaturant concentration was taken into 
account as described (61). ΔG°(H2O)N-I and 
ΔG°(H2O)I-U represent the unfolding free energy 
on going from N to I, and I to U, respectively, in 
the absence of denaturant; mN-I and mI-U are the 
slopes, δ(ΔG°)/δ[GdmCl], of the corresponding 
linear plots of the Gibbs free energy against 
denaturant concentration. R is the gas constant, and 
T is the absolute temperature. The midpoints of the 
transition, i.e., the denaturant concentrations at 
which [I]/[N] and [U]/[I] are equal to unity, are 
given by Cm = - ΔG°(H2O)/m 
The program Grafit 5.0.10 (Erithacus 
Software Ltd.) was used for non-linear least-
squares analysis of the data. Unless otherwise 
stated, errors are reported as standard deviations 
throughout.  
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TABLE 1. Thermodynamic parameters for GdmCl- and urea-induced unfolding transition of apoBcII.  




FIGURE 1. Schematic ribbon representation of the structure of BcII 569/H/9 (1BVT (40)). The zinc ions 
at the catalytic site are represented as yellow spheres, α-helices and β-strands are shown in red and blue, 
respectively, and the four tryptophan residues are labelled and coloured green. The β3-β4 and β11-α4 
loops [residues 32-38(59-66) and 170-188(223-241), respectively] are also indicated. The figure was 
generated using the open-source molecular graphics system PyMol (The PyMOL Molecular Graphics 
System, Version 1.2r3pre, Schrödinger, LLC).  
FIGURE 2. Fluorescence (A,B) and far-UV CD (C,D) spectra of native ([GdmCl] = 0 M, thick line), 
partially folded ([GdmCl] = 2.4 M, dashed line) and unfolded ([GdmCl] = 4 M, thin line) forms of holo 
(A,C) and apo (B,D) BcII. GdmCl-induced equilibrium unfolding transitions of holo (E) and apo (F) BcII 
at pH 7.5 and 25°C, monitored by the change in fluorescence intensity at 370 nm (□), CD at 222 nm (○) 
and enzyme activity (Δ; holoBcII only); the filled squares (■) correspond to the refolding of BcII after 
12 h incubation in 6 M GdmCl, monitored by the change in fluorescence intensity at 370 nm. Data are 
shown as the fractional change in signal (58) at each GdmCl concentration; they were analysed on the 
basis of two- and three-state models for apo and holoBcII, respectively, and the solid lines represent the 
best fit calculated using the thermodynamic values in Tables 1 and 2, respectively. The curve for holoBcII 
unfolding followed by activity measurements is there to guide the eye only. 
FIGURE 3. 2D 1H-15N HSQC spectra for histidine imidazole observation. (A) Superimposition of data 
obtained for native BcII in the presence (holoBcII, in red) and absence (apoBcII, in blue) of zinc ions, 
with no GdmCl; (B) Superimposition of signals observed for holoBcII in the presence of 0 M (blue), 
2.25 M (red) and 2.5 M (green) GdmCl. Note that standard BBL numbering system only is used. 
FIGURE 4. Stern-Volmer plots of holoBcII tryptophan fluorescence, in the presence of 0.1 mM ZnSO4, 
quenched by acrylamide at several GdmCl concentrations. Experiments were performed for the native 
state in the absence of GdmCl (□), the intermediate state in the presence of 2.4 M GdmCl (○) and the 
unfolded state in the presence of 3.5 M GdmCl (∇). Data are the average of at least 3 independent 


















FIGURE 5. 2D 1H-15N HSQC spectra of holoBcII in the presence of various GdmCl concentrations. A: 
[GdmCl] = 0 M; B: [GdmCl] = 1.63 M; C: [GdmCl] = 2.34 M; D: [GdmCl] = 4.0 M. Plots have been 
drawn using CcpNmr Analysis (56). 
FIGURE 6. Overlay of 2D 1H-15N HSQC spectra of holoBcII in the presence of various GdmCl 
concentrations: 0 M (black); 1 M (green); 1.6 M (blue) and 2.34 M (pink). Arrows indicate shifts and their 
directions, circles are for peaks corresponding to the unfolded protein in 2.34 M GdmCl, and arcs indicate 
non-linear CSPs. Residues are numbered as in the sequence, i.e. Lys104(135), Lys134(181), Lys 227(291). 
FIGURE 7. (A) Combined chemical shift perturbations (CSPs) between 0 and 2.34 M GdmCl, calculated 
using equation (2) and shown as histograms versus the BcII amino acid sequence. The dashed line 
represents the threshold (0.064 ppm) for significant chemical shift perturbations calculated as described in 
Materials and Methods. With residues Ile83(113), Glu151(198), Val165(218), Lys176(229), estimation of 
the CSPs was done by linear extrapolation. Those 8 residues [Lys50(78), Thr64(92), Glu72(100), 
Ile83(113), Ala115(146), Thr131(178), Val165(218), Glu188(243)] whose signals disappeared completely 
as GdmCl concentration was increased above 0.75 M (see text) are indicated by asterisk. Sequence 
elements corresponding to loops β3-β4 and β11-α4 are indicated; (B) Schematic ribbon representation of 
the structure where green areas represent those residues undergoing significant CSPs. 
FIGURE 8. Influence of GdmCl on the indole side chain (A) and backbone amide (B) resonances of the 
four tryptophan residues of holoBcII. The combined chemical shift perturbation (CSP) for sidechain Hε1-
Nε1 (A) and backbone H-N peaks (B) plotted as a function of GdmCl concentration. The solvent 
accessibility of the corresponding side and main chains, as computed with NACCESS (69), is indicated. 
FIGURE 9. 2D 1H-15N HSQC spectra for histidine imidazole of BcII in the presence of 2 M GdmCl. (A) 
holoBcII, (B) apoBcII, (C) Zn/apoBcII molar ratio = 1, and (D) Zn/apoBcII molar ratio = 2. Note that 
standard BBL numbering system only is used. 


































33 ± 1.4 21 ± 1 1.5 ± 0.2 33 ± 1 10 ± 0.4 3.3 ± 0.3 























29 ± 6 15 ± 3 1.9 ± 0.8 66 ± 3 24 ± 1 2.8 ± 0.3 
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